| A nationwide cohort study of the incidence of inflammatory bowel disease in Sweden from 1990 to 2014 A Forss, M Clements, D Bergman, B Roelstraete, GG Kaplan, P Myrelid, ... Alimentary Pharmacology & Therapeutics 55 (6), 691-699, 2022 | 33 | 2022 |
| Validating surgical procedure codes for inflammatory bowel disease in the Swedish National Patient Register A Forss, P Myrelid, O Olén, ÅH Everhov, C Nordenvall, J Halfvarson, ... BMC Medical Informatics and Decision Making 19, 1-8, 2019 | 32 | 2019 |
| Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register J Thunberg, O Björkqvist, CRH Hedin, A Forss, C Söderman, ... United European Gastroenterology Journal 10 (7), 631-639, 2022 | 29 | 2022 |
| Ustekinumab is associated with real-world long-term effectiveness and improved health-related quality of life in Crohn's disease A Forss, M Clements, P Myrelid, H Strid, C Söderman, A Wagner, ... Digestive Diseases and Sciences 68 (1), 65-76, 2023 | 14 | 2023 |
| Risk of juvenile idiopathic arthritis and rheumatoid arthritis in patients with celiac disease: A population-based cohort study JB Doyle, B Lebwohl, J Askling, A Forss, PHR Green, B Roelstraete, ... Official journal of the American College of Gastroenterology| ACG 117 (12 …, 2022 | 8 | 2022 |
| Prospective observational study on Stelara (ustekinumab) assessing effectiveness in Crohn’s disease (PROSE): a 16-week follow-up A Forss, M Clements, P Myrelid, H Strid, C Söderman, A Wagner, ... Scandinavian Journal of Gastroenterology 56 (6), 680-686, 2021 | 7 | 2021 |
| Patients with microscopic colitis are at higher risk of major adverse cardiovascular events: a matched cohort study A Forss, D Bergman, B Roelstraete, J Sundström, A Mahdi, H Khalili, ... Clinical Gastroenterology and Hepatology 21 (13), 3356-3364. e9, 2023 | 6 | 2023 |
| Histologic activity in inflammatory bowel disease and risk of serious infections: A nationwide study K Mårild, J Söderling, J Axelrad, J Halfvarson, A Forss, M Olsson, ... Clinical Gastroenterology and Hepatology 22 (4), 831-846, 2024 | 2 | 2024 |
| Antibiotic use and development of nonalcoholic fatty liver disease: A population‐based case–control study F Ebrahimi, TG Simon, H Hagström, J Sun, D Bergman, A Forss, ... Liver International 43 (10), 2186-2197, 2023 | 2 | 2023 |
| The Burden of IBD: Comparing Denmark and Sweden A Forss, JF Ludvigsson, O Olén Gastroenterology, 2022 | 2 | 2022 |
| Prevalence of Coeliac disease in patients with rheumatoid arthritis and juvenile idiopathic arthritis: a systematic review and meta-analysis A Forss, A Sotoodeh, RF van Vollenhoven, JF Ludvigsson Clin Exp Rheumatol October 25, 10.55563, 2023 | 1 | 2023 |
| Long-term risk of arrhythmias in patients with inflammatory bowel disease: A population-based, sibling-controlled cohort study J Sun, B Roelstraete, E Svennberg, J Halfvarson, J Sundström, A Forss, ... PLoS Medicine 20 (10), e1004305, 2023 | 1 | 2023 |
| Antibiotics and risk of IBD—Can we close the books? F Ebrahimi, A Forss Alimentary Pharmacology & Therapeutics 58 (2), 254-255, 2023 | 1 | 2023 |
| Su1529 RISK OF MAJOR ADVERSE CARDIOVASCULAR OUTCOMES IN FAMILIES WITH MASLD: A NATIONWIDE POPULATION-BASED MULTIGENERATIONAL COHORT STUDY F Ebrahimi, R Ebrahimi, H Hagstrom, J Sundstrom, J Sun, D Bergman, ... Gastroenterology 166 (5), S-1625-S-1626, 2024 | | 2024 |
| Mo1134 DIVERTICULAR DISEASE AND RISK OF INCIDENT MAJOR ADVERSE CARDIOVASCULAR EVENTS: A NATIONWIDE MACTHED COHORT STUDY A Forss, W Ma, M Thuresson, J Sun, F Ebrahimi, D Bergman, O Olen, ... Gastroenterology 166 (5), S-945, 2024 | | 2024 |
| Acute interstitial nephritis in patients with inflammatory bowel disease treated with vedolizumab: a systematic review A Forss, P Flis, A Sotoodeh, M Kapraali, S Rosenborg Scandinavian Journal of Gastroenterology, 1-9, 2024 | | 2024 |
| Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study C Eriksson, J Sun, M Bryder, G Bröms, ÅH Everhov, A Forss, T Jernberg, ... Alimentary Pharmacology & Therapeutics, 2024 | | 2024 |
| The epidemiology of inflammatory bowel diseases during the COVID-19 pandemic: comparison of two nationwide cohorts O Atia, N Bryder, A Mendelovici, N Ledderman, A Ben-Tov, M Osooli, ... Journal of Crohn's and Colitis, jjae029, 2024 | | 2024 |
| Prevalence of coeliac disease in patients with systemic lupus erythematosus: a systematic review and meta-analysis A Sotoodeh, MN Hoang, K Hellgren, A Forss Lupus Science & Medicine 11 (1), e001106, 2024 | | 2024 |
| TRENDS IN INFLAMMATORY BOWEL DISEASE INCIDENCE AND PREVALENCE ACROSS EPIDEMIOLOGIC STAGES: A GLOBAL SYSTEMATIC REVIEW WITH META-ANALYSIS J Gorospe, J Windsor, L Hracs, S Coward, M Buie, J Quan, L Caplan, ... Gastroenterology 166 (3), S56-S57, 2024 | | 2024 |
